Thomas Phd Adams Insider Profile

4 Followers
Thomas Phd Adams, EC, Director at Cardiff Oncology, holds 18.88K shares in Cardiff Oncology (Ticker: CRDF), holds ― shares in Hepion Pharmaceuticals (Ticker: HEPA), holds 72.24K shares in Synergy Pharmaceuticals Inc (Ticker: SGYPQ). Most recently, Thomas Phd Adams Bought ― shares of Cardiff Oncology on May 18, 2020 for an estimated value of 20.00K.
tipranks
Thomas Phd Adams

Thomas Phd Adams
Cardiff Oncology (CRDF)
EC, Director

Ranked #6,328 out of 78,624 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+412.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$447K
92.59%
7.41%
0.00%
A breakdown of Thomas Phd Adams's holdings

Insider Roles

Cardiff Oncology
(CRDF)
EC, Director
La Jolla Pharma
(LJPC)
Director
Hepion Pharmaceuticals
(HEPA)
Director
Roles that Thomas Phd Adams holds in companies

Most Profitable Insider Trade

Stock:
Cardiff Oncology
(CRDF)
Rating:Informative Buy
Date:May 18, 2020 - May 18, 2021
Return:+800.00%
The most profitable trade made by Thomas Phd Adams

Thomas Phd Adams's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cardiff Oncology
May 18, 2020
EC, Director
Informative Buy
20.00K
$413.74K
Hepion Pharmaceuticals
Director
SGYPQ
Synergy Pharmaceuticals Inc
Jul 06, 2018
Uninformative Sell
$433.43
La Jolla Pharma
Director
$33.11K
List of latest transactions for each holding click on a transaction to see Thomas Phd Adams's performance on stock

Thomas Phd Adams insider profile FAQ

What is the percentage of profitable transactions made by Thomas Phd Adams?
The percentage of profitable transactions made by Thomas Phd Adams is 100%.
    What is the average return per transaction made by Thomas Phd Adams?
    The average return per transaction made by Thomas Phd Adams is 412.50%.
      What stocks does Thomas Phd Adams hold?
      Thomas Phd Adams holds: CRDF, HEPA, SGYPQ, LJPC stocks.
        What was Thomas Phd Adams’s latest transaction?
        Thomas Phd Adams latest transaction was an Informative Buy of $20.00K.
          What was Thomas Phd Adams's most profitable transaction?
          Thomas Phd Adams’s most profitable transaction was an Informative Buy of CRDF stock on May 18, 2020. The return on the trade was 800.00%.
            What is Thomas Phd Adams's role in Cardiff Oncology?
            Thomas Phd Adams's role in Cardiff Oncology is EC, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.